ALGN Stock Recent News
ALGN LATEST HEADLINES
Align Technology's stock is having its worst day in more than 20 years, as people are spending less on their teeth given concerns about the economy.
SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces that it is investigating potential claims on behalf of investors of Align Technology, Inc. (NASDAQ: ALGN) regarding possible violations of federal securities laws.
Align Technology tumbles 34.2% after Q2 earnings and revenues miss estimates as Clear Aligner sales drop and margins tighten further.
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.4% on Thursday.
Align Technology, Inc. (NASDAQ:ALGN ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants John F. Morici - CFO & Executive VP of Global Finance Joseph M.
The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Align Technology (ALGN) came out with quarterly earnings of $2.49 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $2.41 per share a year ago.
Teeth aligner maker Align Technology on Wednesday cut its annual revenue growth forecast as macroeconomic uncertainties weighed on demand for its dental products, sending the company's shares about 30% lower in extended trading.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the second quarter ("Q2'25"). Q2'25 total revenues were $1,012.4 million, up 3.4% sequentially and down 1.6% year-over-year. Q2'25 total revenues were favorably imp.